At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry.
Location: Germany
Employees: 11-50
Total raised: $16.79M
Founded date: 2016
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.07.2025 | - | $4.33M | - |
| 07.03.2022 | Series A | $12.46M | - |
Mentions in press and media 7
| Date | Title | Description |
| 28.07.2025 | LenioBio Receives EUR3.7M in EU4Health Funding | LenioBio, a Düsseldorf, Germany-based provider of a protein expression platform, received an EUR3.7M EU4Health grant from European Health and Digital Executive Agency (HaDEA) The company intends to allocate the amount to scale its platform ... |
| 14.09.2023 | EIT Food grants €1.8M to three companies for or scaling cultivated meat production | Today, three companies have received €1.8 million from EIT Food to solve the biggest barriers to cultivating meat at scale. The funding follows their participation in the Cultivated Meat Innovation Challenge backed by the international nonp... |
| 03.05.2023 | LenioBio GmbH Announces New CEO | DUSSELDORF, Germany, May 3, 2023 /PRNewswire/ -- LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr. Remberto Martis, will be stepping down as CEO and has proudly named his s... |
| 07.03.2022 | LenioBio Closes €11.5M Series-A Extension Funding | LenioBio GmbH, a Dusseldorf, Germany-based life sciences biotech offering protein manufacturing technology, called ALiCE, closed its Series-A Extension round with a total investment volume of €11.5m. The round was led by current investor Br... |
| 23.03.2021 | Next gen cell-free biomanufacturing could unlock opportunities to biosynthesize far wider set of natural ingredients, claims startup | Right now, says Debut Bio’s co-founder and CEO Dr Joshua Britton, you can extract colors, flavors, and bioactives from plants, which can be expensive, inefficient, and not very sustainable if you’re devoting acres of agricultural land to gr... |
| 26.10.2020 | 21 start-ups reach EIT Health Catapult Final | Twenty-one start-ups from across Europe have secured their places at the EIT Health Catapult Final in December. The EIT Health Catapult, currently in its fifth year, is a training and competition programme that boosts the development of Eu... |
| 13.06.2020 | 42 start-ups reach EIT Health Catapult Semi-finals | The EIT Health Catapult, currently in its fifth year of operation, is a training and competition programme that boosts the development of European health start-ups by exposing them to top quality experts and international investors. The 42... |